Retaglutide and tirzepatide are innovative GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications stimulate insulin secretion from the pancreas, inhibit glucagon release, and delay gastric emptying, leading to improved glycemic control. Retaglutide is administered orally, while tirzepatide u